Related Experiment Video
Updated: Jun 18, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Key aspects of health system change on the path to personalized medicine
1Personalized Health Care Initiative, Office of the Secretary, Department of Health and Human Services, Hubert H. Humphrey Building, Suite 445F.5, 200 Independence Avenue SW, Washington, DC 20201, USA. gregory.downing@hhs.gov
Abstract:
The tools and knowledge base for personalized medicine practices are being developed as a major transformation is underway in our health care system. Although the foundation supporting the scientific and technological applications that enable individualized approaches in health care continues to be framed, an uncertain health care delivery landscape lies ahead, driven by economic, quality-of-care, and other policy considerations. There are commonalities in the needs and the opportunities for personalized medicine and health care system change, and these 2 facets can mutually inform one another. Here, we examine this interface in the dimensions of innovation and costs, health information technology, evidence development and comparative effectiveness, clinical data standards, consumer tools, and patient safety and public health. Indeed, personalized medicine must offer solutions for broader health priorities if it is to achieve its potential impact.
Related Concept Videos
Introduction To Health Care Delivery System
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
